3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease

FEBS Journal

Volumn 272, Issue 19, 2005, Pages 4874-4883

  Yang, Song Yu ^a   He, Xue Ying ^a   Schulz, Horst ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY COLLEGE OF NEW YORK   (United States)

Author keywords

oxidation disorder; Alzheimer's disease; Branched chain fatty acid oxidation; Mental retardation; Parkinson's disease

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; BUTYRYL COENZYME A DEHYDROGENASE; FATTY ACID; ISOLEUCINE;

AGING; ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN REGION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME DEFECT; ENZYME STRUCTURE; FATTY ACID OXIDATION; HEALTH STATUS; HUMAN; MENTAL DEFICIENCY; MITOCHONDRIAL RESPIRATION; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; X LINKED MENTAL RETARDATION;

3-HYDROXYACYL COA DEHYDROGENASES; ALZHEIMER DISEASE; ANIMALS; HEALTH; HUMANS; MENTAL RETARDATION; MITOCHONDRIA; PARKINSON DISEASE;

EID: 26244465858     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04911.x     Document Type: Conference Paper

References (78)

1. Yang SY & He XY (1999) Molecular mechanism of fatty acid β-oxidation enzyme catalysis. Adv Exp Med Biol 466, 133-143.
2. Schulz H (2004) Fatty acid oxidation. In Encyclopedia of Biological Chemistry (Lennarz W & Lane MD, eds), pp. 90-94. Elsevier, San Diego, CA.
3. Roe CR & Ding J (2001) Mitochondrial fatty acid oxidation disorders. In The Metabolic and Molecular Basis of Inherited Disease (Scriver C, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW & Vogelstein B, eds), pp. 2297-2326, 8th edn. McGraw-Hill, New York, NY.
4. Bartlett K & Pourfarzam M (2002) Defects of β-oxidation including carnitine deficiency. Int Rev Neurobiol 53, 469-516.
5. Rinaldo P, Matern D & Benett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64, 477-502.
6. Vockley J & Whiteman DAH (2002) Defects of mitochondrial β-oxidation: a growing group of disorders. Neuromus Disord 12, 235-246.
7. Wakil SJ (1963) β-Hydroxyacyl-CoA dehydrogenase. In The Enzyme (Boyer PD & Myrback K, eds), Vol. 7, pp. 97-103. Academic Press, New York, NY.
8. Noyes BE & Bradshaw RA (1973) L-3-Hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. I. Purification and properties. J Biol Chem 248, 3052-3059.
9. Noyes BE & Bradshaw RA (1973) L-3-Hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. II. Subunit structure. J Biol Chem 248, 3060-3066.
10. He XY, Yang SY & Schulz H (1989) Assay of L-3-hydroxyacyl coenzyme A dehydrogenase with substrates of different chain lengths. Anal Biochem 180, 105-109.
11. He XY, Zhang G, Blecha F & Yang SY (1999) Identity of heart and liver L-3-hydroxyacyl-CoA dehydrogenase. Biochim Biophys Acta 1437, 119-123.
12. Vredendaal PJCM, van den Berg IET, Malingre HEM, Stroobants AK, Olde Weghuis DE & Berger R (1996) Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun 223, 718-723.
13. Vredendaal PJCM, van den Berg IET, Stroobants AK, van der A DL, Malingre HEM & Berger R (1998) Structural organization of the human short-chain L-3-hydroxyacyl-CoA dehydrogenase gene. Mamm Genom 9, 763-768.
14. El-Fakhri M & Middleton B (1982) The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria. Biochim Biophys Acta 713, 270-279.
15. Carpenter K, Pollitt RJ & Middleton B (1992) Human liver long-chain 3-hydoxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. Biochem Biophys Res Commun 183, 443-448.
16. Uchida Y, Izai K, Orii T & Hashimoto T (1992) Novel fatty acid β-oxidation enzymes in rat liver mitochondria, II: purification and properties of enoyl coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 267, 1034-1041.
17. Kamijo T, Aoyama T, Miyazaki J & Hashimoto T (1993) Molecular cloning of the cDNA for the subunits of rat mitochondrial fatty acid β-oxidation multienzyme complex. Structural and functional relationships to other mitochondrial and peroxisomal β-oxidation enzymes. J Biol Chem 268, 26452-26460.
18. Yang SY (1994) The large subunit of the pig heart mitochondrial membrane-bound β-oxidation complex is a long-chain enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. Comp Biochem Physiol 109B, 557-566.
19. He XY, Schulz H & Yang SY (1998) A human brain L-3-hydroxyacyl- coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease. J Biol Chem 273, 10741-10746.
20. Luo MJ, Mao LF & Schulz H (1995) Short-chain 3-hydroxy-2-methylacyl- CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. Arch Biochem Biophys 321, 214-220.
21. Kobayashi A, Jiang LL & Hashimoto T (1996) Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver. J Biochem 119, 775-782.
22. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Colison K, Zhu A, Stern E, Saido T et al. (1997) An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389, 689-695.
23. He XY, Merz G, Yang YZ, Pullarkat R, Mehta P, Schulz H & Yang SY (1999) Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J Biol Chem 274, 15014-15019.
24. He XY, Merz G, Yang YZ, Mehta P, Schulz H & Yang SY (2001) Characterization and localization of human type 10, 17β-hydroxysteroid dehydrogenase. Eur J Biochem 268, 4899-4907.
25. Yang SY, He XY & Schulz H (2005) Multiple functions of type 10, 17beta-hydroxysteroid dehydrogenase. Trends Endocrinol Metab 16, 167-175.
26. Shafqat N, Marschall H, Filling C, Nording E, Wu XQ, Bjork L, Thyberg J, Martensson E, Salim S, Jornvall H & Oppermann U (2003) Expended substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenase reveal multiple specificities in bile acid and steroid hormone metabolism. Characterization of multifunctional 3α/7α/7β/20β/21- hydroxysteroid dehydrogenase. Biochem J 376, 49-60.
27. He XY, Yang YZ, Schulz H & Yang SY (2000) Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short chain L-3-hydroxyacyl-CoA dehydrogenase. Biochem J 345, 139-143.
28. He XY, Merz G, Yang YZ, Pullarkat R, Mehta P, Schulz H & Yang SY (2000) Function of human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism. Biochim Biophys Acta 1484, 267-277.
29. Yang SY & He XY (2001) Role of type 10 17β-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease. Adv Exp Med Biol 487, 101-110.
30. Yan SD, Shi Y, Zhu A, Fu J, Zhu H, Zhu Y, Gibson L, Stern E, Collison K, Al-Mohanna F, Ogawa S, Roher A, Clarke SG & Stern DM (1999) Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity. J Biol Chem 274, 2145-2156.
31. Tieu K, Perier C, Vila M, Caspersen C, Zhang HP, Teismann P, Jackson-Lewis V, Stern DM, Yan SD & Przedborski S (2004) L-3-Hydroxuacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Ann Neurol 56, 51-60.
32. Ofman R, Ruiter JPN, Feenstra M, Duran M, Poll-The BT, Zschocke J, Ensenauer R, Lehnert W, Sass JO, Sperl W & Wanders RJA (2003) 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. Am J Hum Genet 72, 1300-1307.
33. Bradshaw RA & Noyes BE (1975) L-3-Hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. EC 1.1.1.35 L-3-hydroxyacyl-CoA: NAD oxidoreductase. Methods Enzymol 35, 122-128.
34. Birktoft JJ, Holden HM, Hamlin R, Xuong NC & Banaszak LJ (1987) Structure of L-3-hydroxyacyl-CoA dehydrogenase. Preliminary chain tracing at 2.8 Å resolution. Proc Natl Acad Sci USA 84, 8262-8266.
35. Bitar KG, Perez-Aranda A & Bradshaw RA (1980) Amino acid sequence of L-3-hydroxyacyl-CoA dehydrogenase from pig heart muscle. FEBS Lett 116, 196-198.
36. Barycki JJ, O'Brien LK, Bratt JM, Zhang R, Sanishivili R, Strauss AW & Banaszak LJ (1999) Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insight into catalytic mechanism. Biochemistry 38, 5786-5798.
37. Yang SY & Schulz H (1987) Kinetics of coupled enzyme reactions. Biochemistry 26, 5579-5584.
38. Osumi T & Hashimoto T (1980) Purification and properties of mitochondrial and peroxisomal 3-hydroxyacyl-CoA dehydrogenase from rat liver. Arch Biochem Biophys 203, 372-383.
39. Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HEM, Berger R & van den Berg IET (2001) Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J Clinic Invest 108, 457-465.
40. Mao LF, Chu C, Luo MJ, Simon A, Abbas AS & Schulz H (1995) Mitochondrial β-oxidation of 2-methyl fatty acids in rat liver. Arch Biochem Biophys 321, 221-228.
41. Kissinger CR, Rejto PA, Pelletier LA, Thomson JA, Showalter RE, Abreo MA, Agree CS, Margosiak S, Meng JJ, Aust RM et al. (2004) Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. J Mol Biol 342, 943-952.
42. Hashimoto T, Shindo Y, Souri M & Baldwin GS (1996) A new inhibitor of mitochondrial fatty acid oxidation. J Biochem 119, 1196-1201.
43. Barycki JJ, O'Brien LK, Strauss AW & Banaszak LJ (2000) Sequestration of the active site by interdomain shifting: crystalographic and spectroscopic evidence for distinct conformation of L-3-hydroxyacyl-CoA dehydrogenase. J Biol Chem 275, 27186-27196.
44. He XY & Yang SY (1998) Molecular cloning, expression in Escherichia coli, and characterization of a novel L-3-hydroxyacyl coenzyme A dehydrogenase from pig liver. Biochim Biophys Acta 1392, 119-126.
45. He XY & Yang SY (1996) Histidine-450 is the catalytic residue of L-3-hydroxyacyl-coenzyme A dehydrogenase associated with the large α-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli. Biochemistry 35, 9625-9630.
46. He XY, Deng H & Yang SY (1997) Importance of the γ-carboxyl group of glutamate-462 of the large α-subunit for the catalytic function and the stability of the multienzyme complex of fatty acid oxidation from Escherichia coli. Biochemistry 36, 261-268.
47. Barycki JJ, O'Brien LK, Strauss AW & Banaszak LJ (2001) Glutamate 170 of human L-3-hydroxyacyl-CoA dehydrogenase is required for proper orientation of the catalytic histidine and structural integrity of the enzyme. J Biol Chem 276, 36718-36726.
48. Yang SY, He XY, Style J, Luo MJ, Schulz H & Elzinga M (1994) Primary structure of the large subunit of trifunctional β-oxidation complex from pig heart mitochondria. Biochem Biophys Res Commun 198, 431-437.
49. Osumi T, Ishii N, Hijikata M, Kamijo K, Ozasa H, Furuta S, Miyazawa S, Kondo K, Inoue K, Kagamiyama H & Hashimoto T (1985) Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enoyl-CoA: hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. J Biol Chem 260, 8905-8910.
50. Preisig-Muller R, Guhnemann-Schafer K & Kindl H (1994) Domains of the tetrafunctional protein acting in glyoxysomal fatty acid β-oxidation. Demonstration of epimerase and isomerase activities on peptide lacking hydratase activity. J Biol Chem 269, 20475-20481.
51. Yang XYH, Schulz H, Elzinga M & Yang SY (1991) Nucleotide sequence of the promoter and fadB gene of the fadB A operon and primary structure of the multifunctional fatty acid oxidation protein from Escherichia coli. Biochemistry 30, 6788-6795.
52. Shi Y, Samuel SJ, Lee W, Yu C, Zhang W, Lachaal M & Lung CY (1999) Cloning of an L-3-hydroxyacyl-CoA dehydrogenase that interacts with the GLUT4 C-terminus. Arch Biochem Biophys 363, 323-332.
53. Mudlers JWM, Hendriks W, Blankesteijn M, Bloemendal H & de Jong WW (1988) λ-Crystallin, a major rabbit lens protein, is related to hydroxyacyl coenzyme A dehydrogenase. J Biol Chem 263, 15462-15466.
54. Tien I, De Vivo DC, Hale DE, Clarke JTR, Zinman H, Laxer R, Shore A & DiMauro S (1991) Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol 30, 415-419.
55. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P & Burlina AB (1996) Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 39, 185-188.
56. Bennett MJ, Spotswood SD, Ross KF, Comfort S, Koonce R, Boriack RL, IJlst L & Wanders RJA (1999) Fatal hepatic short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial β-oxidation. Pediatr Dev Pathol 2, 337-345.
57. Treacy EP, Lambert DM, Barnes R, Boriack RL, Vockley J, O'Brien LK, Jones PM & Bennett MJ (2000) Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: a family study. J Pediatr 137, 257-259.
58. Luo MJ, He XY, Sprecher H & Schulz H (1993) Purification and characterization of the trifunctional β-oxidation complex from pig heart mitochondria. Arch Biochem Biophys 304, 266-271.
59. 58a O'Brien LK, Rinaldo P, Sims HF, Alonso EM, Charrow J, Jones PM, Bennett MJ, Barycki JJ, Banaszak LJ & Strauss AW (2000) Fulminant hepatic failure associated with mutations in the medium and short chain L-3-hydroxyacyl-CoA dehydrogenase gene. J Inherit Metab Dis 33(S1), 127.
60. Rinaldo P (1999) Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. Dig Dis Sci 44, S97-S102.
61. Caceres JF & Kornblihtt AR (2002) Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 18, 186-193.
62. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72, 291-336.
63. Jornvall H, Persson B, Krook M, Atrian S, Gonzalez-Duarte R, Jeffery J & Ghosh D (1995) Short-chain dehydrogenases/reductases (SDR). Biochemistry 34, 6003-6013.
64. Osumi T & Hashimoto T (1979) Occurrence of two 3-hydroxyacyl-CoA dehydrogenases in rat liver. Biochim Biophys Acta 574, 258-267.
65. He XY, Wegiel J & Yang SY (2005) Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. Brain Res 1040, 29-35.
66. Zschocke J, Rutter JPN, Brand J, Lindner M, Hoffmann GF, Wanders RJA & Mayatepek E (2000) Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatric Res 48, 852-855.
67. Ensenauer R, Niderhoff H, Ruiter JPN, Wanders RJA, Schwab KO, Brandis M & Lehnart W (2002) Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency. Ann Neurol 51, 656-659.
68. Olpin SE, Pollitt RJ, McMenamin J, Manning NJ, Besley G, Buiter JP & Wanders RJA (2002) 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man. J Inherit Metab Dis 25, 477-482.
69. He XY, Wegiel J, Yang YZ, Pullarkat R, Schulz H & Yang SY (2005) Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors. Mol Cell Endocrinol 229, 111-117.
70. Oppermann UCT, Salim S, Tjernberg LO, Terenius L & Jornvall H (1999) Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implication for apoptosis in Alzheimer's disease. FEBS Lett 451, 238-242.
71. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M et al. (2004) ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452.
72. Frackowiak J, Mazur-Kolecka B, Kaczmarski W & Dickson D (2001) Deposition of Alzheimer's vascular amyloid-β is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB). Brain Res 907, 44-53.
73. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I, Currie J & Wisniewski HM (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2, 121-130.
74. Reeves SA, Helman LJ, Allison A & Israel MA (1989) Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc Natl Acad Sci USA 86, 5178-5182.
75. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM & Binder LI (1986) Abnormal phosphorylation of the microtubule associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
76. Dauer W & Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909.
77. Langston JW, Ballard P & Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
78. Przedborski S, Tieu K, Perier C & Vila M (2004) MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr 36, 375-379.